METTL3 and atherosclerosis: described endothelial METTL3 downregulation with consequent epidermal growth factor receptor (EGFR) mRNA m6A-hypomethylation-mediated EGFR upregulation, which was linked with promoted atherosclerosis both in vitro and in vivo.95